I migliori medici per il trattamento di Larynx cancer - TOP-32 medici

1,100+ procedures performed – Dr. Bülent Karagöz specializes in tumor biology and immunotherapy at Anadolu Medical Center.

• 30 years of experience in medical oncology
• Expert in sarcoma, lymphoma, and targeted therapies
• Professor at Istanbul Okan University Faculty of Medicine
• Author of 40+ publications in cancer research
• Member of the Turkish Medical Oncology Association

Dr. Eda Tanrikulu specializes in medical oncology and chemotherapy at Anadolu Medical Center, with a focus on complex cancer cases.

• Completed medical oncology training at Marmara University
• Ranked 3rd in Turkey for minor specialty exam in 2013
• Former head of medical oncology at Haydarpaşa Numune Training and Research Hospital
• Involved in multiple international clinical studies

Dr. Solak specializes in head and neck cancers, with advanced training at Hacettepe University Cancer Institute and MD Anderson Cancer Center.

• Expert in treating larynx cancer among other head and neck cancers
• Fellowship-trained at a top US cancer center
• Works at a JCI-accredited hospital with advanced technology

Prof. Sezer Sağlam brings extensive expertise in medical oncology, including a focus on larynx cancer, at Gayrettepe Florence Nightingale Hospital.

• Professor of Medical Oncology since 2016
• Specialized in gastrointestinal oncology
• Member of ESMO, ASCO, and Turkish Medical Oncology Association

Professor Doctor Sefik Igdem specializes in radiation oncology, focusing on head and neck cancers at Gayrettepe Florence Nightingale Hospital.

• Over 25 years of experience in radiation oncology
• Expert in conformal treatments and advanced technologies like Truebeam Stx
• Professor at T.R Demiroğlu Bilim University
• Trained at Istanbul University Cerrahpaşa Faculty of Medicine

Head of Medical Oncology at Yüzüncü Yıl University – Dr. Sakin brings deep expertise in larynx cancer treatment at Medipol Bahçelievler Hospital.

• Specialized in Medical Oncology at İstanbul Okmeydanı Training and Research Hospital
• Former Education Officer at Prof. Dr. Cemil Taşçıoğlu City Hospital
• Extensive experience in oncology with roles across multiple leading hospitals

Professor Yesim Yildirim has authored 80+ publications on cancer care and specializes in immunotherapy for larynx cancer at Anadolu Medical Center.

• Member of ESMO and ESO with rigorous oncology training
• Expert in precision medicine and targeted cancer therapies
• Professor at Halic University, mentoring future oncologists
• Fellowship-trained at Rambam Medical Centre and Mount Vernon

Specialist Dr. Rahib Hasanov brings international expertise from Houston Methodist Hospital and focuses on personalized oncology treatments like immunotherapies and targeted therapies.

• Trained at Istanbul University Cerrahpaşa and Marmara University
• Specializes in gastrointestinal, urogenital, and breast cancers
• Incorporates smart drugs and modern treatment methods
• Treats patients from multiple countries, including Europe and the US

Professor Saglam brings over 20 years of experience in medical oncology at Gayrettepe Florence Nightingale Hospital.

• Specializes in gastrointestinal oncology since 2005
• Professor at Istanbul University Oncology Institute
• Member of ESMO, ASCO, and Turkish Medical Oncology Association
• Trained at prestigious Istanbul University and Ege University

Dr. Topcu specializes in treating larynx cancer among various other cancers, with extensive training at renowned international cancer centers.

• Trained at MD Anderson Cancer Center and Sunnybrook Odette Cancer Center
• Specialized in Medical Oncology from Karadeniz Technical University
• Experienced in treating a wide range of cancers including head and neck cancers
• Works at Valued Med Hub Hospitals

Specializes in medical oncology with a focus on larynx cancer – treating patients at Medical Park Antalya Hospital Complex.

• Trained at Akdeniz University Faculty of Medicine
• Over 8 years of dedicated oncology experience
• Member of Medical Park Antalya's specialized oncology team

Dr. Yildiz has published extensively on neuroendocrine tumors and rare cancer cases, with research featured in international medical journals.

• Specializes in gastroenteropancreatic neuroendocrine tumors
• Published 17+ peer-reviewed articles on oncology
• Works at Medipol Mega University Hospital
• Experienced in diagnosing rare cancer presentations

Professor of Otolaryngology – Orhan Gazi Yigitbasi brings academic expertise to treating larynx cancer at Medipol Mega University Hospital.

• Holds a professorship in Otolaryngology
• Practices at a leading university hospital
• Specializes in head and neck conditions

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Over 10 years of experience in oncology
• Worked at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital
• Promoted to Associate Professor in 2016
• Trained at Selcuk University Faculty of Medicine

Dr. Ercan Ozden specializes in medical oncology with extensive experience in treating larynx cancer and improving patient outcomes.

• Over 20 years of experience in internal medicine and oncology
• Completed medical oncology subspecialty at Kocaeli University Faculty of Medicine
• Skilled in comprehensive treatment planning for laryngeal malignancies
• Fluent in English and Turkish, ensuring clear communication with international patients

Assoc. Prof. Nail Paksoy brings extensive oncology expertise to Medipol Bahçelievler Hospital, with a focus on larynx cancer treatment.

• ESMO Board Certified in Medical Oncology
• Participated in 8 international clinical trials as subinvestigator
• Published multiple studies on cancer treatment outcomes
• Specialized training at Istanbul University Oncology Institute

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Karatas brings extensive international training in otolaryngology and head-neck surgery, with specialized fellowships across Europe and the US.

• Trained at prestigious institutions including Hannover Medical School and The Ohio State University
• Member of multiple professional societies including the American Academy of Otolaryngology
• Specializes in advanced surgical techniques for head and neck cancers
• Works at Atlas University Hospital with a focus on complex cases

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.